Related Experiment Video
Updated: Jun 16, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Progress in the pharmacotherapy of gout
1Division of Pulmonary Allergy and Critical Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. john.sundy@duke.edu
Purpose Of Review:
To summarize new knowledge on approved and emerging drugs used to treat hyperuricemia or the clinical manifestations of gout.
Recent Findings:
Results of several clinical trials provide new data on the efficacy and safety of the approved urate-lowering drugs, allopurinol and febuxostat. New recommendations have been presented on appropriate dosing of colchicine for acute gout flares and potential toxicities of combining colchicine with medications such as clarithromycin. Emerging therapies, including pegloticase, the uricosuric agent RDEA596, and the interleukin-1 inhibitors, rilonacept and canakinumab, have shown promise in early and late phase clinical trials.
Summary:
Recent publications demonstrate an opportunity to use existing gout therapies more effectively in order to improve both efficacy and safety. Emerging therapies for gout show promise for unmet needs in selected gout populations.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care